4 Amendments of Doru-Claudian FRUNZULICĂ related to 2016/2096(INI)
Amendment 5 #
Draft opinion
Paragraph 1
Paragraph 1
1. Notes with concern that gender discrimination and inequalities occur in health and social care research in developing countries, thereby affecting the development of appropriate and targeted treatments; recalls that women's different biological and physiological make-up requires proper information about the effect of drugs on their bodies;
Amendment 12 #
Draft opinion
Paragraph 2
Paragraph 2
2. Calls on governments of developing countries to mainstream gender in mental health policy, and to develop policies and programmes that address both the specific needs of women for mental health treatment and the social origins of psychological distress; notes with concern that, especially in Least Developed Countries, the exclusion of women from biomedical research is often caused by lack of information and awareness campaign, their fulfilment of their role as mothers and caregivers and their lack of decision-making freedom in their household; strongly believes that better balance in gender roles and obligations, income security, access to education, the development of social safety nets and poverty reduction would further redress gender disparities in mental health;
Amendment 17 #
Draft opinion
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Calls on the European Commission to address the root causes of the failure to include and retain adequate numbers of women in clinical trials and to yield meaningful information about treatment and burden of disease, and to allocate resources for more research, prevention, treatment and support services for women;
Amendment 29 #
Draft opinion
Paragraph 4
Paragraph 4
4. Notes with concern that the increase in offshoring medicine testing to Africa may result in serious ethical violations; points out that not having access to affordable healthcare or health insurance, as well as access to affordable medicine, gives vulnerable people, particularly women, no other choice than to participate in clinical trials in order to receive medical treatment;